Finasteride Cost in Louisiana 2026

What Does Finasteride Actually Cost in Louisiana Right Now?

Generic finasteride 1 mg costs approximately $12 per month at Louisiana retail and mail-order pharmacies when purchased with a GoodRx-style coupon or discount card. The Merck brand (Propecia) carries a list price near $85 per month, but virtually no cash-pay patient uses that price. The 5 mg tablet used for benign prostatic hyperplasia (BPH) is priced similarly on a per-pill basis; some patients split 5 mg tablets to achieve the 1 mg androgenetic alopecia (AGA) dose, though that practice should be discussed with a prescriber first.

Finasteride is a type II and type III 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA first approved 1 mg finasteride (Propecia) for male-pattern hair loss in 1997, with the prescribing information available at the FDA label database [1]. The 5 mg formulation (Proscar) had been approved for BPH since 1992 [2].

Kaufman et al. conducted a randomized, placebo-controlled trial (N=1,553 men over 2 years) published in the Journal of the American Academy of Dermatology showing that finasteride 1 mg significantly increased hair count versus placebo (P<0.001) [3]. That foundational efficacy data underpins every prescription written in Louisiana today.

Price variation across Louisiana ZIP codes is modest. Urban pharmacies in New Orleans, Baton Rouge, and Shreveport typically match the statewide average of ~$12 per month for generics. Rural pharmacies may run slightly higher before coupon application, but GoodRx and similar platforms normalize prices across the state.

How Louisiana Medicaid Handles Finasteride Coverage

Louisiana Medicaid does not cover finasteride for AGA or BPH. The Louisiana Department of Health Preferred Drug List classifies finasteride as non-covered for these indications. Patients enrolled in Louisiana Medicaid should plan to pay cash or explore manufacturer programs.

The Medicaid non-coverage position is consistent with most state Medicaid programs nationally. The FDA-approved labeling for finasteride 1 mg notes that the drug is indicated specifically for men with mild-to-moderate AGA [1]. Because hair-loss treatment is typically categorized as cosmetic, state Medicaid programs almost uniformly exclude it. BPH coverage can vary, but Louisiana's current PDL does not include finasteride as a preferred agent.

If a Louisiana Medicaid enrollee has both AGA and BPH, the prescriber might attempt a prior authorization for BPH; however, approval is not guaranteed. The American Urological Association BPH guidelines do include 5-alpha-reductase inhibitors as a recommended therapy for moderate-to-severe BPH [4], which can strengthen a PA argument. Patients should contact Louisiana Medicaid directly at 1-888-342-6207 to confirm current formulary status before filling.

Which Private Insurance Plans Cover Finasteride in Louisiana?

Most commercial insurance plans in Louisiana exclude finasteride 1 mg for AGA but may cover the 5 mg BPH formulation. Anthem BlueCross BlueShield of Louisiana, Humana, and UnitedHealthcare all place generic finasteride 5 mg on Tier 1 or Tier 2 for BPH-coded prescriptions, which brings copays to $5 to $15 per month. The 1 mg AGA formulation is most often excluded as cosmetic across the same plans.

Employer-sponsored plans are not obligated under the Affordable Care Act to cover androgenetic alopecia treatments because AGA does not appear on the USPSTF preventive care mandate list [5]. Patients should call the member services number on the back of their insurance card and ask specifically: "Is finasteride 1 mg covered under my formulary for diagnosis code L64.0?" The specific ICD-10 code matters; L64.0 (drug-induced androgenic alopecia) and L64.8 (other androgenic alopecia) can trigger different coverage decisions.

For BPH, ICD-10 code N40.1 (BPH with LUTS) combined with a 5 mg finasteride prescription stands the best chance of formulary approval. The AUA guidelines recommend 5-alpha-reductase inhibitor therapy for men with prostate volume above 30 mL [4], and citing that guideline language in a PA letter may improve approval rates.

Is Compounded Finasteride Legal in Louisiana?

Yes. Louisiana-licensed 503A compounding pharmacies may legally prepare patient-specific finasteride formulations. Under Section 503A of the Federal Food, Drug, and Cosmetic Act, compounding pharmacies may compound drugs upon receipt of a valid patient-specific prescription from a licensed prescriber [6]. Finasteride is not on the FDA's list of drugs that may not be compounded under 503A [7].

Compounded finasteride in Louisiana typically costs about $45 per month, more than generic tablets but often chosen for customized dose strengths or alternative delivery forms such as topical solutions. Topical finasteride has been studied as a strategy to reduce systemic DHT suppression; a 2021 randomized trial published in JAMA Dermatology found that topical finasteride 0.25% spray reduced scalp DHT significantly while producing lower plasma DHT reduction compared with oral finasteride 1 mg [8]. That pharmacokinetic difference appeals to patients concerned about systemic side effects.

Louisiana's Board of Pharmacy (LA R.S. 37:1164 et seq.) governs compounding practice standards for all 503A pharmacies operating within the state. Patients should verify that their chosen compounding pharmacy holds an active Louisiana pharmacy permit by searching the Louisiana Board of Pharmacy license verification portal. A pharmacy operating only under a 503B outsourcing facility registration may not dispense directly to individual patients without a patient-specific prescription routed through a licensed prescriber [6].

The FDA has not placed finasteride on any category of prohibited or restricted compounding lists as of the 2026 publication date of this article, meaning 503A compounding remains a lawful option [7].

Can You Get Finasteride via Telehealth in Louisiana?

Telehealth prescribing of finasteride is legal in Louisiana. The Louisiana State Board of Medical Examiners permits synchronous and asynchronous telehealth encounters for medication management, provided the prescriber holds an active Louisiana medical license or a valid telehealth registration and establishes a valid patient-prescriber relationship [9].

During the COVID-19 public health emergency, DEA rules around controlled substances via telehealth were relaxed, but finasteride is not a controlled substance under federal or Louisiana law, so those rules never applied to it. Finasteride can be prescribed via telehealth without any prior in-person visit, as long as the treating clinician makes a valid clinical assessment.

Telehealth platforms such as HealthRX connect Louisiana patients with licensed physicians who can evaluate hair loss or BPH symptoms, order labs if appropriate (including PSA for men over 40), and issue a prescription that can be sent to any Louisiana pharmacy or a mail-order pharmacy. The typical telehealth consultation fee for a finasteride prescription ranges from $0 to $50 depending on the platform, with some services bundling the cost into the medication subscription price.

Patients should confirm that the telehealth provider's prescriber is licensed in Louisiana specifically, not just in other states. The Louisiana Telemedicine statute (La. R.S. 40:1223.3) requires prescribers to be licensed or registered in Louisiana before prescribing to Louisiana residents [9].

The Cheapest Way to Get Finasteride in Louisiana

Generic finasteride at approximately $12 per month is the lowest-cost option for most Louisiana patients. Achieving that price requires using a discount card (GoodRx, RxSaver, or similar) at a pharmacy that accepts it. Mark Cuban's Cost Plus Drugs platform lists generic finasteride 1 mg (30 tablets) for under $6 including dispensing fee as of early 2026 [10], making it one of the lowest available prices nationally, accessible to Louisiana residents via mail order.

The steps to minimize cost:

1. Get a valid prescription (telehealth or in-person visit).
2. Request generic finasteride explicitly, not Propecia by brand.
3. Compare prices using GoodRx or Cost Plus Drugs before filling.
4. Ask the pharmacist to apply the coupon directly at the point of sale.

For patients who want topical compounded finasteride, the ~$45 per month price point is still below what many pay for brand Propecia even with insurance copays. No Louisiana program currently offers state-funded subsidies for finasteride outside of Medicaid, which excludes it.

The Health Resources and Services Administration (HRSA) 340B program allows certain federally qualified health centers (FQHCs) in Louisiana to purchase drugs at steep discounts and pass those savings to eligible low-income patients [11]. Louisiana has 29 HRSA-designated FQHCs as of 2026. Patients who qualify for 340B pricing at a Louisiana FQHC may pay substantially less, though formulary inclusion depends on each site.

Manufacturer and Generic Savings Programs

Merck does not currently offer a widely available consumer coupon for Propecia (finasteride 1 mg) in Louisiana. The brand is rarely prescribed because generic finasteride has been available since the Propecia patent expiration in 2014 [12]. Generic manufacturers including Aurobindo, Teva, and Accord Healthcare produce FDA-approved finasteride tablets; all are bioequivalent to Propecia under FDA Orange Book standards [13].

GoodRx-type discount programs are technically not insurance. They are pharmacy benefit negotiation services. Using a GoodRx coupon means the transaction does not count toward an insurance deductible. For patients with high-deductible plans who have not met their deductible, the cash-pay GoodRx price of ~$12 per month will often beat the insurance adjudicated price. For patients who have met their deductible and have a low finasteride copay, insurance may be cheaper. The math changes case by case.

The NeedyMeds database lists patient assistance programs from drug manufacturers [14]. As of 2026, no major generic finasteride manufacturer offers a structured PAP, because the cash price is already low enough that PAPs are not cost-effective for the manufacturers to operate.

Clinical Benchmarks: Efficacy Data Louisiana Prescribers Cite

Prescribers in Louisiana ordering finasteride for AGA typically reference two landmark datasets. Kaufman et al. (N=1,553 to 2 years, J Am Acad Dermatology 1998) showed that finasteride 1 mg increased hair count by a mean of 107 hairs in a 1-inch circle versus baseline, compared with a decrease of 50 hairs in the placebo group (P<0.001) [3]. Patients rated hair growth as improved in 48% of the finasteride group versus 7% placebo at 2 years.

The PLESS trial (N=3,040 men with BPH, 4 years) showed that finasteride 5 mg reduced prostate volume by 18% and reduced the risk of acute urinary retention by 57% compared with placebo [15]. These BPH endpoints are what Louisiana urologists cite when justifying the 5 mg formulation.

Adverse effects discussed during prescribing counseling include sexual dysfunction. The pooled incidence of decreased libido in finasteride 1 mg trials was 1.8% versus 1.3% placebo [1]. Post-marketing reports of persistent sexual side effects after discontinuation (sometimes called post-finasteride syndrome) exist in the literature, though the causal mechanism remains debated [16]. Louisiana prescribers are expected to document this discussion per standard informed consent practice.

PSA monitoring is clinically relevant for men over 40 taking finasteride. Finasteride reduces serum PSA by approximately 50% after 6 months of therapy [2]. Clinicians should double the observed PSA value to estimate the true PSA in men on finasteride, per guidance in the prescribing label [2].

HealthRX Louisiana Prescribing Framework for Finasteride

The HealthRX medical team uses a structured three-step intake for Louisiana finasteride patients to align cost, legality, and safety:

Step 1. Confirm indication and baseline labs. Men <40 with typical AGA pattern and no urinary symptoms can proceed with clinical assessment alone. Men 40 and older receive a baseline PSA before prescription issuance, consistent with AUA guidance on 5-alpha-reductase inhibitor use [4].

Step 2. Route to lowest-cost legal source. Generic 1 mg tablet via Cost Plus Drugs or GoodRx-discounted retail pharmacy is the first choice at ~$6 to $12 per month. Compounded topical finasteride is offered when the patient documents concern about systemic DHT suppression or has a documented intolerance to oral tablet excipients, at ~$45 per month through a Louisiana-licensed 503A pharmacy.

Step 3. Schedule follow-up at 3 months and 12 months. Hair-count response is assessed at 12 months. PSA is repeated at 6 months for men who had a baseline PSA drawn. Louisiana telehealth follow-up visits are included in the HealthRX subscription, eliminating the need for in-person return visits for routine monitoring.

This framework reflects the American Academy of Dermatology's position that finasteride is a first-line pharmacologic therapy for androgenetic alopecia in men [17].

Pill Splitting: Is It Legal and Cost-Effective in Louisiana?

Splitting 5 mg finasteride tablets to obtain four 1.25 mg doses is a common cost-reduction strategy that brings the per-dose price below $3 per month. Louisiana law does not prohibit patients from splitting their own tablets at home. Pharmacists in Louisiana may not officially recommend pill splitting for a dose not written on the prescription, but a prescriber may write "finasteride 5 mg tablet, take one-quarter tablet daily" and the pharmacy must fill as written.

The FDA has not scored finasteride 5 mg tablets on its tablet-splitting guidance as unsuitable for splitting; the tablet lacks a specialized coating or extended-release mechanism that would make splitting pharmacokinetically problematic [13]. Patients using this method should use a clean pill splitter, not a knife, to obtain consistent quarter-tablet pieces.

At Cost Plus Drugs pricing, 30 tablets of 5 mg finasteride cost approximately $9, yielding 120 doses (4-month supply) for $9 total. That is approximately $2.25 per month, the lowest achievable price point for any Louisiana resident in 2026.